Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 23, 2003

View Archived Issues

Alcon claims three series of 5-HT2 agonists with utility in glaucoma therapy

Researchers report production of fully active antibodies in algae chloroplasts

Novel series of erythromycin analogues designed at Pfizer

Uniroyal researchers identify novel antiretroviral agents for HIV and HCMV infections

Water-soluble antifungal compounds covered by Sankyo patent

Novel antagonists of platelet ADP (P2YAC) receptors discovered at Schering AG

Celera patent covers the preparation and use of new cathepsin S inhibitors

Scientists at Boehringer Ingelheim present novel tachykinin antagonists and their uses

Hynic-Annexin V IND withdrawn, to be resubmitted at later date

AxCell Biosciences and Celgene team up for ubiquitin ligase research

ALT-711 reduces left ventricular mass in DIAMOND trial

Asmanex Twisthaler launched in U.K.

Lamictal approved for adjunctive use in pediatric partial seizures

Coley earns CpG-7279 milestone payment from Aventis

Phase I study initiated for P-63

RK-0202 enters phase II evaluation in oral mucositis

Inhale Therapeutic Systems becomes Nektar Therapeutics

IPD-1151T licensed to Yamanouchi for global development in cystitis and prostatitis

Inhibition of endogenous cannabinoid breakdown as a novel antianxiety strategy

Yamanouchi team discovers new antifungal antibiotic with novel mechanism

Novartis stops development of DRF-4158 but continues collaboration with Dr. Reddy's

Efficacy of TAK-427 in experimental model of atopic dermatitis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...